Such effects were found to be counteracted after treatment with hedgehog inhibitors, so targeting this signalling in CA‐MSCs can reduce the expression of TGF‐β, turn the tumour‐immune ecosystem into hot, and restore responses to the anti‐PD‐L1 therapy.33 The gene discussed is TGFB1; the disease is neoplasm.